- American Society for Reproductive Medicine
- United States of America
About Fertility and Sterility
Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.
Popular Contributions
A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome
The combination of letrozole and clomiphene citrate was associated with a higher ovulation rate compared with letrozole alone in women with infertility and poly- cystic ovary syndrome.
What are patients doing with their mosaic embryos? Decision making after genetic counseling
Patient decisions regarding mosaic-embryo transfer were assessed. More than one-fourth of patients without euploid embryos pursued transfer; those who pursued additional treatment had a greater chance of ongoing pregnancy.
One hundred mosaic embryos transferred prospectively in a single clinic: exploring when and why they result in healthy pregnancies
Chromosomal mosaicism in embryos can exist in a variety of forms, and different characteristics determine the clinical outcome of mosaic embryo transfers.
Effect of class III and class IV obesity on oocyte retrieval complications and outcomes
Oocyte retrieval in class III and class IV obesity patients requires alterations to anesthetic and procedural approaches but can be safely performed in tertiary care settings.
Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist
Cycle day, E2 level, and follicle size at time of antagonist start are all independent predictors of clinical pregnancy after IVF.